Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
Eur J Med Chem. 2017 Sep 29;138:480-490. doi: 10.1016/j.ejmech.2017.06.065. Epub 2017 Jun 29.
The clerodane diterpenoids 16-oxo-cleroda-3, 13(14) E-diene-15 oic acid (1) and kolavenic acid (2) isolated from Polyalthia longifolia var. pendula (Linn.) were previously reported for their antimicrobial activity. Thus present study was designed to investigate the biofilm inhibiting potential of these diterpenoids (1-2) and five new lactone derivatives (3-7) of 1 against methicillin resistant Staphylococcus aureus (MRSA), Streptococcus mutans, Klebsiella pneumoniae and Proteus mirabilis. Compounds 1 and 3 at 10-20 μg/mL were found to be bacteriostatic and significantly reduced the biofilm formation and metabolically active cells of MRSA and S. mutans up to 90%. Parental diterpenoid (1) at 10 and 16 μg/mL significantly eradicated the preformed biofilm of both pathogens. Both the compounds also delayed acid production at minimum inhibitory (MIC) and sub-inhibitory concentrations (sub MIC). Florescence and scanning electron microscopy further confirms the biofilm inhibiting potential of compounds 1 and 3 and displayed disrupted biofilms at MIC and sub MIC levels. The gene expression of MRSA and S. mutans responsible for biofilm formation was also altered. Moreover, the observed anti-virulence properties and delayed bacterial growth after 10 min of exposure to the test compounds 1 and 3 make them a promising class of antibiofilm agents.
从聚醛叶下珠(Linn.)中分离得到的 clerodane 二萜 16-氧 cleroda-3,13(14) E-二烯-15 烯酸(1)和 kolavenic 酸(2)先前已报道具有抗菌活性。因此,本研究旨在研究这些二萜(1-2)和 1 的五个新内酯衍生物(3-7)对耐甲氧西林金黄色葡萄球菌(MRSA)、变形链球菌、肺炎克雷伯菌和奇异变形杆菌的生物膜抑制潜力。化合物 1 和 3 在 10-20μg/mL 时被发现具有抑菌作用,并显著降低了 MRSA 和 S. mutans 的生物膜形成和代谢活性细胞,最高可达 90%。母体二萜(1)在 10 和 16μg/mL 时显著消除了两种病原体的已形成生物膜。两种化合物还在最小抑菌浓度(MIC)和亚抑菌浓度(sub MIC)下延迟了酸的产生。荧光和扫描电子显微镜进一步证实了化合物 1 和 3 的生物膜抑制潜力,并在 MIC 和 sub MIC 水平下显示出破坏的生物膜。MRSA 和 S. mutans 负责生物膜形成的基因表达也发生了改变。此外,在暴露于测试化合物 1 和 3 10 分钟后观察到的抗毒力特性和延迟细菌生长使它们成为有前途的一类抗生物膜剂。